Gabriella Abruzzo
Climate Projects Officer, Health Care Without Harm Europe (HCWH)

Valérie Paris joined the OECD Secretariat in September 2005 to contribute to the work undertaken by the Health Division. Since then, she has contributed to several projects on health systems’ characteristics and performance, providers’ payments, pharmaceutical policies and regional variations in health care use. She co-ordinated and co-authored the OECD reports New Health Technologies - Managing Access, Value and Sustainability (2017) ; Pharmaceutical Innovation and Access to Medicines (2018) and Securing medical supply chain in a post-pandemic world (2024). She is responsible for most OECD projects related to pharmaceuticals and medical devices.
Between 2020 to 2023, Valérie Paris was appointed member of the Board of French National Authority for Health, Chair of the HAS Economic Evaluation and Public Health Committee and Vice-Chair of the Vaccine Committee. Previously, she was researcher at the French Institute of Research and Information on Health Economics (IRDES), a non-for-profit organization. She participated in research projects on pharmaceutical policies, physicians’ payment schemes, health accounts and comparative analysis of health systems.
She holds a master’s degree in Economics, statistics and econometrics from the University of Paris 1-Sorbonne (1990).
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, European Alcohol Policy Alliance
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Executive Director, EUPATI
Movement Health, Executive Director
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Board Chair, Czech National Association of Patient Organizations (NAPO) & Board Member, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
Youth Group Member, European Patients' Forum (EPF)
President, European Liver Patient Association (ELPA)
Head of Government Affairs, EMEA MedTech, Johnson & Johnson
Professor, Sorbonne Université
Regional Director, WHO/Europe
Youth Group Member, European Patients' Forum (EPF)
Director for Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
Director General, EFPIA
IMMUcan scientific lead
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Executive Director, Biomed Alliance
SVP International, Butterfly Network Inc
Director General, AESGP
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Head of Unit, Policy and Coordination, HERA, European Commission
More speakers Announced soon
Stay Tuned!
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Regional Innovation Lead, NHS Greater Glasgow and Clyde Board (NHSGGC)
Policy Officer, European Patients' Forum (EPF)
PhD, MBA. Secretary of the Board, HTAi
Policy Officer, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)
More moderators Announced soon
Stay Tuned!